Healthcare and Life Science
Human immune system is ‘ready to go’ long before birth
By creating the first spatial atlas of the developing human thymus, a vital organ that trains immune cells to protect against infections and cancer, scientists have discovered that the foundation for lifelong immunity is established earlier than previously thought. ...
Shining a light on the life sciences
The OBN Awards struck an optimistic tone as the best of the UK’s life sciences industry was celebrated Abingdon, UK, 21 November 2024: – OBN (UK) Ltd is thrilled to announce the winners of the prestigious OBN Awards 2024. This was the 16th year of the Awards, which OBN (UK) Ltd, the no...
Medicilon delivers fast turnaround time to meet your FDA submission deadline for SEND Format Conversion
Medicilon's preclinical pharmacology and toxicology research team is equipped with a professional send format conversion team and has established a send data conversion platform that is fully developed in terms of software, technology, specification and quality, to realize accurate data...
Glox Therapeutics awarded £1M PACE grant to accelerate development of precision antibiotics against antimicrobial-resistant pathogens
Novel therapeutics to address unmet clinical need for pneumonias caused by drug-resistant Escherichia coli and Klebsiella pneumoniae PACE provides funding and support for innovative, high value, high risk, early phase drug discovery and diagnostic projects Glasgow, UK, 20 November...
COPD management: a critical look at gaps in pharmaceutical innovation
Chronic Obstructive Pulmonary Disease (COPD) presents a major global health challenge, marked by chronic respiratory decline and frequent exacerbations. Despite advances in treatment, comprehensive management strategies remain limited, revealing significant gaps in patient care. ...
CrestOptics and Tomocube partner to advance 3D imaging with new multimodal imaging platform
First commercially available spinning-disk confocal holotomographic instrument, enabling advanced 3D imaging with fluorescence-based detection New system showcased at SPAOM24 (20th-22nd November, Toledo, Spain) Rome, IT, 20 November, 2024: CrestOptics S.p.A., a manufacturer of high...
Tagomics announces a multiomic profiling co-marketing agreement with Agilent
Exclusive program will provide customers with a single, unified workflow for comprehensive genomic profiling and genome-wide epigenetic analysis ...
Asimov and RevOpsis Therapeutics sign licensing agreement for high titer multispecific-expressing cell line
Strategic agreement will accelerate the manufacturing of fully human multispecific therapies for chronic retinal diseases with high unmet need using Asimov’s CHO Edge System ...
Steritas announces collaboration with argenx to advance evidence for novel steroid-sparing therapeutics
First-in-class steroid-toxicity outcome assessments licensed by argenx to support development of novel steroid-sparing therapeutics for autoimmune diseases Boston, MA, USA, 19 November 2024: Steritas LLC., a company dedicated to enhancing care for steroid-treated patients, announces a ...
Enterprise Therapeutics publishes on medicinal chemistry of ETD001, a novel inhaled ENaC blocker for treatment of cystic fibrosis
Paper in the European Journal of Medicinal Chemistry discloses the optimisation process leading to the selection for development of ETD001, an inhaled ENaC blocker with a best-in-class profile ETD001 commenced Phase 2 clinical study in people with cystic fibrosis in July 2024 Brig...